MTE #40 - Metabolic Alterations as Drivers of Progressive Liver Fibrosis and Portal Hypertension

Nov 13 2023
Room 204 - Hynes Convention Center
7:30 - 8:15 AM EST

Description

The aim is to discuss metabolic alterations that are involved in liver fibrosis and portal hypertension.

Objectives

  • Gain an in-depth understanding of the metabolic alterations involved in the progression of liver fibrosis and the development of portal hypertension
  • Identify key metabolic pathways and cell types that contribute to the pathogenesis of progressive liver fibrosis and portal hypertension
  • Explore potential therapeutic targets and interventions aimed at modulating metabolic dysregulation to mitigate liver fibrosis and portal hypertension progression